Breast cancer in the setting of fertility-sparing treatment for endometrial cancer.
Publication
, Journal Article
Moss, HA; Frey, MK; Blank, SV
Published in: Gynecol Oncol Rep
December 2014
•Progesterone therapy is a commonly used alternative to surgical management for women with endometrial cancer who desire fertility preservation.•Prior research suggests that progestins may contribute to breast tumorigenesis.•We report a patient diagnosed with progesterone receptor positive breast cancer during hormonal treatment of endometrial cancer.
Duke Scholars
Published In
Gynecol Oncol Rep
DOI
ISSN
2352-5789
Publication Date
December 2014
Volume
10
Start / End Page
30 / 31
Location
Netherlands
Citation
APA
Chicago
ICMJE
MLA
NLM
Moss, H. A., Frey, M. K., & Blank, S. V. (2014). Breast cancer in the setting of fertility-sparing treatment for endometrial cancer. Gynecol Oncol Rep, 10, 30–31. https://doi.org/10.1016/j.gore.2014.10.002
Moss, Haley A., Melissa K. Frey, and Stephanie V. Blank. “Breast cancer in the setting of fertility-sparing treatment for endometrial cancer.” Gynecol Oncol Rep 10 (December 2014): 30–31. https://doi.org/10.1016/j.gore.2014.10.002.
Moss HA, Frey MK, Blank SV. Breast cancer in the setting of fertility-sparing treatment for endometrial cancer. Gynecol Oncol Rep. 2014 Dec;10:30–1.
Moss, Haley A., et al. “Breast cancer in the setting of fertility-sparing treatment for endometrial cancer.” Gynecol Oncol Rep, vol. 10, Dec. 2014, pp. 30–31. Pubmed, doi:10.1016/j.gore.2014.10.002.
Moss HA, Frey MK, Blank SV. Breast cancer in the setting of fertility-sparing treatment for endometrial cancer. Gynecol Oncol Rep. 2014 Dec;10:30–31.
Published In
Gynecol Oncol Rep
DOI
ISSN
2352-5789
Publication Date
December 2014
Volume
10
Start / End Page
30 / 31
Location
Netherlands